Influence of different types of contact hypersensitivity on imiquimod-induced psoriasis-like inflammation in mice

Bai,Shuang; Zhang,Zhenying; Hou,Suchun; Liu,Xiaoming

doi:10.3892/mmr.2016.5299

Influence of different types of contact hypersensitivity on imiquimod-induced psoriasis-like inflammation in mice

Authors:
- Shuang Bai
- Zhenying Zhang
- Suchun Hou
- Xiaoming Liu
View Affiliations

Affiliations: Department of Dermatology and Venereology, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116011, P.R. China, Department of Dermatology and Venereology, The University of Hong Kong‑Shenzhen Hospital, Shenzhen, Guangdong 518053, P.R. China
Published online on: May 18, 2016 https://doi.org/10.3892/mmr.2016.5299
Pages: 671-680
Copyright: © Bai et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

It is currently believed that psoriasis and allergic contact dermatitis (ACD) are different diseases; however, they share clinical similarities. The involvement of T helper 17 (Th17) cells in these disorders provides a novel opportunity to investigate the relationship between them. The present study aimed to determine whether the same or overlapping inflammatory pathways are involved in the two diseases, and the influence of different types of ACD on psoriasis. Compound mouse models of Th1 or Th2‑type contact hypersensitivity (CHS) combined with imiquimod (IMQ)‑induced psoriasis‑like inflammation were established, in order to mimic the characteristics of ACD and psoriasis. Histopathology, immunohistochemistry and cytokine detection in blood serum and tissues were used to compare the differences between the mice treated with IMQ alone or IMQ combined with Th1 and Th2‑type CHS. As compared with the IMQ‑treated mice or IMQ-treated Th1‑type CHS mice, the mice with Th2‑type CHS treated with IMQ exhibited more serious psoriasis‑like inflammation with increased epidermal thickness and infiltrating cells in the derma. High mRNA expression levels of interleukin (IL)‑17, IL‑22, IL‑23, TNF‑α and RORγt were detected in back skin lesions. Additionally, high levels of IL‑17 and IL‑22 in blood serum were detected in IMQ‑treated mice combined with Th2‑type CHS. The mice treated with IMQ alone, and IMQ treatment combined with Th1‑type CHS had a comparable psoriasis‑like inflammatory response in the back skin. In conclusion, these data demonstrate that Th2‑type CHS exacerbated the IMQ‑treated psoriatic inflammation of mice via the IL‑23/IL‑17 axis. Th17 cells and associated pathways may link ACD and psoriasis. Therefore, patients with psoriasis should avoid contact with specific sensitizers, such as fragrance and rubber products, which may induce Th2 polarization.

View Figures

View References

1	Bangsgaard N, Engkilde K, Thyssen JP, Linneberg A, Nielsen NH, Menné T, Skov L and Johansen JD: Inverse relationship between contact allergy and psoriasis: Results from a patient- and a population-based study. Br J Dermatol. 161:1119–1123. 2009. View Article : Google Scholar : PubMed/NCBI
2	Guttman-Yassky E, Nograles KE and Krueger JG: Contrasting pathogenesis of atopic dermatitis and psoriasis-part I: Clinical and pathologic concepts. J Allergy Clin Immunol. 127:1110–1118. 2011. View Article : Google Scholar : PubMed/NCBI
3	Guttman-Yassky E, Nograles KE and Krueger JG: Contrasting pathogenesis of atopic dermatitis and psoriasis-part II: Immune cell subsets and therapeutic concepts. J Allergy Clin Immunol. 127:1420–1432. 2011. View Article : Google Scholar : PubMed/NCBI
4	Camargo CM, Brotas AM, Ramos-e-Silva M and Carneiro S: Isomorphic phenomenon of Koebner: Facts and controversies. Clin Dermatol. 31:741–749. 2013. View Article : Google Scholar : PubMed/NCBI
5	Kurz C, Wunderlich S, Spieler D, Schwaiger BJ, Andres C, Traidl-Hoffmann C and Ilg R: Acute transverse myelitis and psoriasiform dermatitis associated with Sjoegren's syndrome: A case report. BMC Res Notes. 7:5802014. View Article : Google Scholar : PubMed/NCBI
6	Jain S, Kaur IR, Das S, Bhattacharya SN and Singh A: T helper 1 to T helper 2 shift in cytokine expression: An autoregulatory process in superantigen-associated psoriasis progression? J Med Microbiol. 58:180–184. 2009. View Article : Google Scholar : PubMed/NCBI
7	Martin DA, Towne JE, Kricorian G, Klekotka P, Gudjonsson JE, Krueger JG and Russell CB: The emerging role of IL-17 in the pathogenesis of psoriasis: Preclinical and clinical findings. J Invest Dermatol. 133:17–26. 2013. View Article : Google Scholar
8	Lynde CW, Poulin Y, Vender R, Bourcier M and Khalil S: Interleukin 17A: Toward a new understanding of psoriasis pathogenesis. J Am Acad Dermatol. 71:141–150. 2014. View Article : Google Scholar : PubMed/NCBI
9	Michalak-Stoma A, Bartosińska J, Kowal M, Juszkiewicz-Borowiec M, Gerkowicz A and Chodorowska G: Serum levels of selected Th17 and Th22 cytokines in psoriatic patients. Dis Markers. 35:625–631. 2013. View Article : Google Scholar : PubMed/NCBI
10	Nakajima K: Critical role of the interleukin-23/T-helper 17 cell axis in the pathogenesis of psoriasis. J Dermatol. 39:219–224. 2012. View Article : Google Scholar : PubMed/NCBI
11	Works MG, Yin F, Yin CC, Yiu Y, Shew K, Tran TT, Dunlap N, Lam J, Mitchell T, Reader J, et al: Inhibition of TYK2 and JAK1 ameliorates imiquimod-induced psoriasis-like dermatitis by inhibiting IL-22 and the IL-23/IL-17 axis. J Immunol. 193:3278–3287. 2014. View Article : Google Scholar : PubMed/NCBI
12	Honda T, Egawa G, Grabbe S and Kabashima K: Update of immune events in the murine contact hypersensitivity model: Toward the understanding of allergic contact dermatitis. J Invest Dermatol. 133:303–315. 2013. View Article : Google Scholar
13	Sugaya M, Kuwano Y, Suga H, Miyagaki T, Ohmatsu H, Kadono T, Okochi H, Blauvelt A, Tamaki K and Sato S: Lymphatic dysfunction impairs antigen-specific immunization, but augments tissue swelling following contact with allergens. J Invest Dermatol. 132:667–676. 2012. View Article : Google Scholar
14	Nakajima S, Kitoh A, Egawa G, Natsuaki Y, Nakamizo S, Moniaga CS, Otsuka A, Honda T, Hanakawa S, Amano W, et al: IL-17A as an inducer for Th2 immune responses in murine atopic dermatitis models. J Invest Dermatol. 134:2122–2130. 2014. View Article : Google Scholar : PubMed/NCBI
15	Dhingra N, Shemer A, Correa da Rosa J, Rozenblit M, Fuen-tes-Duculan J, Gittler JK, Finney R, Czarnowicki T, Zheng X, Xu H, et al: Molecular profiling of contact dermatitis skin identifies allergen-dependent differences in immune response. J Allergy Clin Immunol. 134:362–372. 2014. View Article : Google Scholar : PubMed/NCBI
16	Hopkins JE, Naisbitt DJ, Kitteringham NR, Dearman RJ, Kimber I and Park BK: Selective haptenation of cellular or extra-cellular protein by chemical allergens: Association with cytokine polarization. Chem Res Toxicol. 18:375–381. 2005. View Article : Google Scholar : PubMed/NCBI
17	Ogawa A, Yoshizaki A, Yanaba K, Ogawa F, Hara T, Muroi E, Takenaka M, Shimizu K, Hasegawa M, Fujimoto M, et al: The differential role of L-selectin and ICAM-1 in Th1-type and Th2-type contact hypersensitivity. J Invest Dermatol. 130:1558–1570. 2010. View Article : Google Scholar : PubMed/NCBI
18	Larsen JM, Bonefeld CM, Poulsen SS, Geisler C and Skov L: IL-23 and T (H)17-mediated inflammation in human allergic contact dermatitis. J Allergy Clin Immunol. 123:486–492. 2009. View Article : Google Scholar
19	van Beelen AJ, Teunissen MB, Kapsenberg ML and de Jong EC: Interleukin-17 in inflammatory skin disorders. Curr Opin Allergy Clin Immunol. 7:374–381. 2007. View Article : Google Scholar : PubMed/NCBI
20	Louten J, Boniface K and de Waal Malefyt R: Development and function of TH17 cells in health and disease. J Allergy Clin Immunol. 123:1004–1011. 2009. View Article : Google Scholar : PubMed/NCBI
21	Jovanović M, Boza P, Karadaglić D, Brkić S, Petrović A, Mimica-Dukić N, Anackov G and Poljacki M: Contact sensitivity in patients with psoriasis in Vojvodina. Int Arch Allergy Immunol. 148:311–320. 2009. View Article : Google Scholar
22	Pigatto PD: Atopy and contact sensitization in psoriasis. Acta Derm Venereol Suppl (Stockh). 19–20. 2000. View Article : Google Scholar
23	van der Fits L, Mourits S, Voerman JS, Kant M, Boon L, Laman JD, Cornelissen F, Mus AM, Florencia E, Prens EP and Lubberts E: Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis. J Immunol. 182:5836–5845. 2009. View Article : Google Scholar : PubMed/NCBI
24	Qin S, Wen J, Bai XC, Chen TY, Zheng RC, Zhou GB, Ma J, Feng JY, Zhong BL and Li YM: Endogenous n-3 polyunsaturated fatty acids protect against imiquimod-induced psoriasis-like inflammation via the IL-17/IL-23 axis. Mol Med Rep. 9:2097–2104. 2014.PubMed/NCBI
25	Onoue A, Kabashima K, Kobayashi M, Mori T and Tokura Y: Induction of eosinophil- and Th2-attracting epidermal chemokines and cutaneous late-phase reaction in tape-stripped skin. Exp Dermatol. 18:1036–1043. 2009. View Article : Google Scholar : PubMed/NCBI
26	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar
27	Rabin RL and Levinson AI: The nexus between atopic disease and autoimmunity: A review of the epidemiological and mechanistic literature. Clin Exp Immunol. 153:19–30. 2008. View Article : Google Scholar : PubMed/NCBI
28	Ghoreschi K, Weigert C and Röcken M: Immunopathogenesis and role of T cells in psoriasis. Clin Dermatol. 25:574–580. 2007. View Article : Google Scholar : PubMed/NCBI
29	Cai Y, Fleming C and Yan J: New insights of T cells in the pathogenesis of psoriasis. Cell Mol Immunol. 9:302–309. 2012. View Article : Google Scholar : PubMed/NCBI
30	Al-Robaee AA, Al-Zolibani AA, Al-Shobili HA, Kazamel A and Settin A: IL-10 implications in psoriasis. Int J Health Sci (Qassim). 2:53–58. 2008.
31	Weigert C, Röcken M and Ghoreschi K: Interleukin 4 as a potential drug candidate for psoriasis. Expert Opin Drug Discov. 3:357–368. 2008. View Article : Google Scholar : PubMed/NCBI
32	Nishimoto S, Kotani H, Tsuruta S, Shimizu N, Ito M, Shichita T, Morita R, Takahashi H, Amagai M and Yoshimura A: Th17 cells carrying TCR recognizing epidermal autoantigen induce psoriasis-like skin inflammation. J Immunol. 191:3065–3072. 2013. View Article : Google Scholar : PubMed/NCBI
33	Singh TP, Schön MP, Wallbrecht K, Michaelis K, Rinner B, Mayer G, Schmidbauer U, Strohmaier H, Wang XJ and Wolf P: 8-methoxypsoralen plus ultraviolet A therapy acts via inhibition of the IL-23/Th17 axis and induction of Foxp3+regulatory T cells involving CTLA4 signaling in a psoriasis-like skin disorder. J Immunol. 184:7257–7267. 2010. View Article : Google Scholar : PubMed/NCBI
34	Lowes MA, Russell CB, Martin DA, Towne JE and Krueger JG: The IL-23/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses. Trends Immunol. 34:174–181. 2013. View Article : Google Scholar : PubMed/NCBI
35	Nakagawa R, Yoshida H, Asakawa M, Tamiya T, Inoue N, Morita R, Inoue H, Nakao A and Yoshimura A: Pyridone 6, a pan-JAK inhibitor, ameliorates allergic skin inflammation of NC/Nga mice via suppression of Th2 and enhancement of Th17. J Immunol. 187:4611–4620. 2011. View Article : Google Scholar : PubMed/NCBI
36	Volpe E, Pattarini L, Martinez-Cingolani C, Meller S, Donnadieu MH, Bogiatzi SI, Fernandez MI, Touzot M, Bichet JC, Reyal F, et al: Thymic stromal lymphopoietin links keratinocytes and dendritic cell-derived IL-23 in patients with psoriasis. J Allergy Clin Immunol. 134:373–381. 2014. View Article : Google Scholar : PubMed/NCBI
37	Moss C, Friedmann PS and Shuster S: Impaired contact hypersensitivity in untreated psoriasis and the effects of photochemotherapy and dithranol/UV-B. Br J Dermatol. 105:503–508. 1981. View Article : Google Scholar : PubMed/NCBI
38	Bangsgaard N, Engkilde K, Menné T, Løvendorf M, Jacobsen GK, Olsen J and Skov L: Impaired hapten sensitization in patients with autoimmune disease. Clin Exp Immunol. 165:310–317. 2011. View Article : Google Scholar : PubMed/NCBI
39	Hajdarbegovic E, Nijsten T, Westgeest A, Habraken F, Hollestein L and Thio B: Decreased prevalence of atopic features in patients with psoriatic arthritis, but not in psoriasis vulgaris. J Am Acad Dermatol. 68:270–277. 2013. View Article : Google Scholar
40	Caca-Biljanovska N, V'Lckova-Laskoska M, Balabanova-Stefanova M and Grivceva-Panovska V: Frequency of delayed-type hypersensitivity to contact allergens in palmo-plantar psoriasis. Prilozi. 26:131–141. 2005.
41	Krupashankar DS and Manivasagam SR: Prevalence and relevance of secondary contact sensitizers in subjects with psoriasis. Indian Dermatol Online J. 3:177–181. 2012. View Article : Google Scholar : PubMed/NCBI
42	Malhotra V, Kaur I, Saraswat A and Kumar B: Frequency of patch-test positivity in patients with psoriasis: A prospective controlled study. Acta Derm Venereol. 82:432–435. 2002. View Article : Google Scholar